DPA made a short submission to Pharmac about the proposal to change the access criteria for COVID-19 antiviral treatments.

We believe the criteria has been set too tightly and ask that it is amended to "include people with single conditions that mean they are at high risk of their pre-existing condition worsening or hospitalisation as a result of COVID-19 infections”.

Read the DPA submission on access criteria for COVID-19 antivirals [Word].